BioSpace News Archive

Business

Blueprint Medicines to Report Second Quarter 2018 Financial Results on Wednesday, August 1, 2018

Blueprint Medicines Corporation announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, August 1, 2018 to report its second quarter 2018 financial results and provide a corporate update.

July 25, 2018
·
1 min read
Genetown

New Personal Dosimeter Provides Ultra-Precise Radiation Dose Detection

Thermo Scientific EPD TruDose electronic personal dosimeter includes advanced telemetry capabilities, ergonomics and design

July 25, 2018
·
2 min read
Drug Development

Tolero Pharmaceuticals Announces First Patient Dosed with Investigational Agent TP-0184, an Activin A Receptor Type 1 (ACVR1) Inhibitor, in Phase 1 Study of Patients with Advanced Solid Tumors

Tolero Pharmaceuticals, Inc. announced that the first patient has been dosed in a Phase 1 study evaluating investigational agent TP-0184

July 25, 2018
·
4 min read
Business

World’s first Center for Female Reproductive Longevity and Equality established at the Buck Institute

The Buck Institute for Research on Aging announced today that it is establishing the world’s first Center for Female Reproductive Longevity and Equality.

July 25, 2018
·
2 min read
Twelve Indiana communities join fight against Alzheimer’s disease during Alzheimer’s Association Walk to End Alzheimer’s® this fall

Participants raise critical awareness & funds for Alzheimer’s care, support, research

July 25, 2018
·
2 min read
Inversago Pharma Receives $7 Million in Series A Financing

Proceeds will support the development of new generations of cannabinoid-1 receptor inverse agonists for the treatment of several metabolic diseases including Prader-Willi Syndrome and type 1 diabetes.

July 25, 2018
·
4 min read
Bio NC

PPD Expands Central Labs’ Preclarus® Technology, Helping Clients Accelerate and Enhance Clinical Research Decision-Making

Pharmaceutical Product Development, LLC (PPD) has expanded its central lab technology capabilities integrated with Preclarus®

July 25, 2018
·
3 min read
Drug Development

Sunovion Announces Positive Top-Line Results from Pivotal Study Evaluating Dasotraline in Adults with Binge Eating Disorder

Study met its primary endpoint demonstrating fewer binge days per week with dasotraline versus placebo in the treatment of adults with moderate to severe binge eating disorder.

July 25, 2018
·
9 min read
Business

Q Biomed Inc. Extends its Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma and Initiates a Clinical Study

Q BioMed Inc. is pleased to announce that it is extending its option agreement with Washington University in St. Louis.

July 25, 2018
·
4 min read
Policy

Centurion BioPharma Corporation Announces Filing of a Provisional Patent Application

Breakthrough Personalized Medicine Companion Diagnostic Filed for its Albumin-binding Drug Candidates

July 25, 2018
·
5 min read